Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - OPERATING INCOME
Operating Income AKBA - Akebia Therapeutics, Inc.
-46.3 M
LAST VALUE
58.25%
2 YEAR CAGR
23.64%
5 YEAR CAGR
-11.25%
10 YEAR CAGR